O, T., & G, D. D. (2021). Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy. Molecules (Basel, Switzerland), 26(24), . https://doi.org/10.3390/molecules26247561
Chicago Style (17th ed.) CitationO, Tatli, and Dinler Doganay G. "Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy." Molecules (Basel, Switzerland) 26, no. 24 (2021). https://doi.org/10.3390/molecules26247561.
MLA (9th ed.) CitationO, Tatli, and Dinler Doganay G. "Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy." Molecules (Basel, Switzerland), vol. 26, no. 24, 2021, https://doi.org/10.3390/molecules26247561.
Warning: These citations may not always be 100% accurate.